Patent · US Active

Anti-tumor drug, medicament, composition, and use thereof

US9539306B2 · kind B2 · utility

3Cited by

13References

9Claims

0Family size

Assignee

GENE SIGNAL INTERNATIONAL SA · CH

Inventors

Salman Al Mahmood · Paris, FR
Sylvie Colin · Paris, FR

Key dates

Filing date	Jan 17, 2014
Grant date	Jan 10, 2017
Priority date	—
Expiry date	Jan 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/47
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method for the treatment of cancers and/or tumors by administration of a polypeptide having the sequence SEQ ID NO:4 or a polypeptide having an amino acid SEQ ID NO Y which, when aligned with SEQ ID N: 4, has (a) a percentage of identical residues over SEQ ID NO: 4 length of at least 50%, and (b) a percentage of identical residues over a amino acid sequence SEQ ID NO Y length of at least 65% or fragments thereof having at least 20 contiguous amino acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.